Previous 10 | Next 10 |
Mind Medicine (MindMed), Inc. (MNMD) Q3 2022 Earnings Conference Call November 10, 2022, 08:30 ET Company Participants Robert Barrow - CEO & Director Schond Greenway - CFO Daniel Karlin - Chief Medical Officer Conference Call Participants Charles ...
In recent years, emerging studies involving psychedelics have found that hallucinogenic drugs can be effective at treating a variety of mental health conditions . These clinical trials and studies have revealed that when paired with psychotherapy, psychedelics can result in positive and pro...
Mind Medicine press release ( NASDAQ: MNMD ): Q3 GAAP EPS of -$0.56 beats by $0.03 . As of September 30, 2022, MindMed had cash and cash equivalents totaling $154.5 million compared to $133.5 million as of December 31, 2021. MindMed believes its available cash and cash...
MindMed Reports Third Quarter 2022 Financial Results and Business Highlights Canada NewsWire – Initiated Phase 2b dose-optimization trial in patients with Generalized Anxiety Disorder, with first patients dosed in Q3 2022 and key clinical readout expected in...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Based in New York, Mind Medicine (NASDAQ: MNMD ) is a psychedelic-medicine developer that’s sometimes informally known as MindMed. Before investing in this company, it’s important to know that MNMD ...
DiPT (N,N-diisopropyltryptamine) is a psychedelic drug of the tryptamine family that induces auditory hallucinations. This means that unlike other hallucinogens which cause visual hallucinations by affecting an individual’s visual sense, DiPT causes hallucinations where an individu...
SHERIDAN, Wyo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Today, FCM MM HOLDINGS, LLC (“FCM”) notifies shareholders that it has formally filed a complaint (the “Complaint”) with the Securities and Exchange Commission (the “SEC”) and will file a referral to ...
MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update Canada NewsWire NEW YORK , Nov. 3, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clini...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Risk is part of investing. Even the most mature, well-established firms and stocks run the risk of declining to zero. However, that risk is even higher with speculative penny stocks. At the same, these less-established fir...
Summary Today, we circle back on a small developmental firm called COMPASS Pathways after the stock was the subject of multiple buy recommendations last week. The company its advancing its lead candidate, which is a psychedelic drug treatment across several indications in mid to l...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
2024-07-26 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...